SEP 10, 2026 · PHASE 1/2 TRIAL
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
ClinicalTrials.gov
This is a clinical trial registry record for a Phase 1/2 umbrella study with no results posted; it describes planned enrollment and study design only.
Reported
Planned enrollment1132
Primary outcome measureObjective Response Rate (ORR)
Follow-up durationup to approximately 12 years